J Nutr Health Aging. 2018;22(8):982-988 © Serdi and Springer-Verlag International SAS, part of Springer Nature DEFINING THE OPTIMAL TARGET POPULATION FOR TRIALS OF POLYUNSATURATED FATTY ACID SUPPLEMENTATION USING THE ERYTHROCYTE OMEGA-3 INDEX: A STEP TOWARDS PERSONALIZED PREVENTION OF COGNITIVE DECLINE? 1,2 3 3 3 1,4 1,2 N. COLEY , R. RAMAN , M.C. DONOHUE , P.S. AISEN , B. VELLAS , S. ANDRIEU FOR THE MAPT/DSA STUDY GROUP* 1. INSERM-Toulouse University UMR1027, Toulouse France; 2. Toulouse University Hospital, Department of Epidemiology and Public Health, Toulouse, France; 3. Alzheimer’s Therapeutic Research Institute, University of Southern California, San Diego, CA, USA; 4. Toulouse University Hospital, Gérontopôle, Department of Geriatric Medicine, Toulouse, France. * members are listed at the end of the manuscript. Corresponding author: Nicola Coley, Faculté de Médecine, 37 allées Jules Guesde, 31000 Toulouse, France, Tel: +33 (0)5 61 14 56 80, Email: email@example.com Abstract: Objectives: to identify the optimal erythrocyte omega-3 index cut-off for predicting cognitive decline and/or polyunsaturated fatty acid (PUFA) treatment response, in order to better define the target population for future dementia prevention trials. Design & Setting: Secondary exploratory analysis of the randomized controlled MAPT prevention trial. Participants: 724 dementia-free subjects aged 70 or older with
The Journal of Nutrition, Health & Aging – Springer Journals
Published: May 31, 2018
It’s your single place to instantly
discover and read the research
that matters to you.
Enjoy affordable access to
over 18 million articles from more than
15,000 peer-reviewed journals.
All for just $49/month
Query the DeepDyve database, plus search all of PubMed and Google Scholar seamlessly
Save any article or search result from DeepDyve, PubMed, and Google Scholar... all in one place.
Get unlimited, online access to over 18 million full-text articles from more than 15,000 scientific journals.
Read from thousands of the leading scholarly journals from SpringerNature, Elsevier, Wiley-Blackwell, Oxford University Press and more.
All the latest content is available, no embargo periods.
“Hi guys, I cannot tell you how much I love this resource. Incredible. I really believe you've hit the nail on the head with this site in regards to solving the research-purchase issue.”Daniel C.
“Whoa! It’s like Spotify but for academic articles.”@Phil_Robichaud
“I must say, @deepdyve is a fabulous solution to the independent researcher's problem of #access to #information.”@deepthiw
“My last article couldn't be possible without the platform @deepdyve that makes journal papers cheaper.”@JoseServera